Pfizer, BioNTech seek approval of 2nd bivalent COVID-19 vaccine in Switzerland

Retrieved on: 2022-09-22 14:49:53

Tags for this article:

Health

Articles

Vaccination

Virology

Federal Department of Home Affairs

Pharmaceuticals policy

Swissmedic

Pfizer

Severe acute respiratory syndrome–related coronavirus

Vaccine

omicron

Click the tags to see associated articles and topics

Pfizer, BioNTech seek approval of 2nd bivalent COVID-19 vaccine in Switzerland. View article details on hiswai:

Excerpt

Pfizer (PFE) and BioNTech (BNTX) are seeking Swissmedic authorization of a second bivalent COVID-19 vaccine.The updated Comirnaty vaccine contains ...

Article found on: seekingalpha.com

View Original Article